HMMS in Action: Transforming Hospital Medicines Management

March 12, 2026|1:00 PM GMT|Past event

Ireland's hospital pharmacies are midway through a national switch to a unified digital medicines system, with 12 more sites set to go live in 2026 or face continued inefficiencies in drug tracking and patient safety.

Key takeaways

  • The HSE's HMMS rollout has already succeeded at several major hospitals since 2023 and targets completion at 12 additional sites in 2026, driven by the National Service Plan and EU-funded digital health priorities.
  • Hospitals stand to gain precise visibility of medicine usage and costs, cutting waste and errors, while patients benefit from safer dispensing in a system previously hampered by fragmented legacy tools.
  • National standardisation clashes with local operational realities, and disruptions during implementation risk temporary service strains in an already pressured health network.

Accelerating Digital Medicines Control

Ireland's Health Service Executive is pushing forward with the Hospital Medicines Management System (HMMS), a centrally deployed national platform designed to modernise pharmacy operations in hospitals and community settings. The system replaces outdated, site-specific software with a single-instance solution that tracks medicines from procurement through to patient administration, integrating with patient records and reporting tools for better oversight.

The urgency stems from the phased rollout gaining momentum: early sites like University Hospital Galway went live in 2023, followed by others including the Rotunda, St. Vincent's University Hospital, and CHI Crumlin in 2025. The HSE plans to hit 12 more go-lives in 2026, aligning with its National Service Plan commitments and the broader digital transformation agenda that includes e-prescribing and a national medicinal product catalogue.

At stake are tangible improvements in patient safety—better traceability reduces dispensing errors—and financial control, as hospitals gain unprecedented visibility into drug expenditure amid rising costs and supply pressures. Inefficiencies in traditional stock management have long contributed to waste and obscured patterns of use across the public system.

Yet the transition carries risks: go-lives demand intensive change management, new specialist pharmacy roles, and integration with varied hospital systems, potentially causing short-term operational friction. Tensions exist between the drive for uniform national data sharing and the practicalities of diverse hospital environments, especially as Ireland pursues wider interoperability goals that may extend beyond current timelines.

We use cookies to measure site usage. Privacy Policy